(Q38649732)

5 September 2017

1 reference

title

Problems in the use of anticancer drugs in the elderly (English)

1 reference

5 September 2017

Phister JE

1

1 reference

5 September 2017

Jue SG

series ordinal

2

1 reference

5 September 2017

Cusack BJ

series ordinal

3

1 reference

5 September 2017

1 April 1989

1 reference

5 September 2017

1 reference

5 September 2017

37

1 reference

5 September 2017

551-565

1 reference

5 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198937040-00007

5 September 2017

0 references

cites work

Drug use in the elderly: a review of problems and special considerations

1 reference

12 December 2020

The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination

1 reference

12 December 2020

Age dependence of the early-phase pharmacokinetics of doxorubicin

1 reference

12 December 2020

Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Lack of age-dependent cisplatin nephrotoxicity

1 reference

12 December 2020

Aggressive management of cancer in the elderly

1 reference

12 December 2020

Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy

1 reference

12 December 2020

Clinical pharmacology of chemotherapeutic agents in old age.

1 reference

12 December 2020

Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience

1 reference

12 December 2020

Hodgkin's disease in patients over sixty years old

1 reference

12 December 2020

Clinical value of the creatinine clearance before the administration of chemotherapy with cisplatin.

1 reference

12 December 2020

Psychosocial consequences of cancer chemotherapy for elderly patients

1 reference

12 December 2020

Clinical pharmacology of bleomycin and cisplatin

1 reference

12 December 2020

Longitudinal studies on the rate of decline in renal function with age.

1 reference

12 December 2020

Cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearance

1 reference

12 December 2020

Cancer in the elderly: basic science and clinical aspects

1 reference

12 December 2020

Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiography

1 reference

12 December 2020

Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study

1 reference

12 December 2020

The disposition of cytotoxic drugs in the elderly

1 reference

12 December 2020

Renal function in the elimination of oral melphalan in patients with multiple myeloma.

1 reference

12 December 2020

Phase II evaluation of bleomycin.A Southwest Oncology Group study

1 reference

12 December 2020

Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs

1 reference

12 December 2020

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

The management of leukaemia in the elderly

1 reference

12 December 2020

Radiation therapy for the aging patient

1 reference

12 December 2020

Aging and drug disposition: an update

1 reference

12 December 2020

Renal function and the rate of disappearance of methotrexate from serum

1 reference

12 December 2020

Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group

1 reference

12 December 2020

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1 reference

12 December 2020

The anemia of senescence

1 reference

12 December 2020

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule.

1 reference

12 December 2020

Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites

1 reference

12 December 2020

Cancer, clinical pharmacology, and aging.

1 reference

12 December 2020

10.2165/00003495-198937040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference